Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
06/2002
06/06/2002DE10051858A1 Verwendung von biologisch abbaubaren, substituierten Kohlenwasserstoffen deren Ester, Ether und/oder Amide als Nasensalbe oder Nasentropfen zur Prophylaxe von inhalationsallergischen Reaktionen und zur Pflege der Nasenschleimhaut Use of biologically degradable, substituted hydrocarbons their esters, ethers and / or amides as a nasal ointment or nasal drops for the prophylaxis of inhalation allergic reactions and for the care of the nasal mucosa
06/06/2002CA2430485A1 Cytonkine receptor zcytor19
06/06/2002CA2430354A1 4-6-diphenyl pyridine derivatives as antiinflammatory agents
06/06/2002CA2430311A1 Compounds active at the glucocorticoid receptor ii
06/06/2002CA2430139A1 Stable, aerosolizable suspensions of proteins in ethanol
06/06/2002CA2430137A1 Method for the stabilizing of biomolecules (e.g. insulin) in liquid formulations
06/06/2002CA2430133A1 Cyclic salen-metal compounds: reactive oxygen species scavengers useful as antioxidants in the treatment and prevention of diseases
06/06/2002CA2430039A1 Methods of administering/dosing anti-rsv antibodies for prophylaxis and treatment
06/06/2002CA2429665A1 Method of making particles for use in a pharmaceutical composition
06/06/2002CA2429615A1 Determination of risk and treatment of complications of prematurity
06/06/2002CA2429469A1 Human elongase genes and uses thereof
06/06/2002CA2429382A1 Indole-type inhibitors of p38 kinase
06/06/2002CA2428552A1 Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension
06/06/2002CA2428026A1 Methods of treatment comprising administration of substance p
06/06/2002CA2422729A1 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
06/05/2002EP1210943A1 New use for budesonide and formoterol
06/05/2002EP1210455A1 Novel glycosyl sulfotransferases gst-4 alpha, gst-4 beta, and gst-6
06/05/2002EP1210426A2 Polymorphisms in a klotho gene
06/05/2002EP1210419A2 Human transmembrane proteins
06/05/2002EP1210350A1 Water soluble sdz-rad esters
06/05/2002EP1210346A2 New active marine alkaloids
06/05/2002EP1210335A1 Aminocarbonyl-substituted benzimidazole derivatives, method for producing same and the use thereof as medicaments
06/05/2002EP1210327A2 New vitamin d derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments
06/05/2002EP1210325A1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha
06/05/2002EP1210320A1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha
06/05/2002EP1210121A2 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties
06/05/2002EP1210094A1 Herbal compositions and uses for the treatment of allergic reactions
06/05/2002EP1210078A1 Improved topical medicaments and methods for photodynamic treatment of disease
06/05/2002EP1210069A2 Large porous particles by spray-drying
06/05/2002EP1210068A2 Use of simple amino acids to form porous particles
06/05/2002EP1210067A2 Modulation of release from dry powder formulations
06/05/2002EP1210063A1 Compositions and methods for enhanced absorption of hydrophilic therapeutic agents
06/05/2002EP1209986A1 Metal-containing compositions, preparations and uses
06/05/2002EP1137438B1 Formulation with an improved therapeutic range, containing nucleotide synthesis inhibitors
06/05/2002EP1121112B1 Stable formoterol concentrate
06/05/2002EP0888337B1 Piperidone tachykinin antagonists
06/05/2002EP0711282B1 Compounds as pde iv and tnf inhibitors
06/05/2002CN1352686A Cytokine receptor chain
06/05/2002CN1352651A Method for inhibiting macrophage infiltration using monoconal anti-alpha-D-antibodies
06/05/2002CN1352644A I-amino triazolo [4,3-alpha] quinazoline -5-ones and/or -5-thiones inhibiting phosphodiesterase IV
06/05/2002CN1352636A Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same
06/05/2002CN1352563A Use of phyllanthus for targeted stimulation of the immune system
06/05/2002CN1352554A IL-8 receptor antagaonists
06/05/2002CN1352550A Acidic buffered nasal spray
06/05/2002CN1352545A 吲哚衍生物 Indole derivatives
06/05/2002CN1085945C 7-(2-imidazolinylamino) quinoline compounds as alpha -2 adrenocepter agonists
06/04/2002US6399780 Kinase inhibitors; anticancer agents
06/04/2002US6399657 Antiinflammatory agents
06/04/2002US6399656 Using a benzopyran-3-carboxamide compound
06/04/2002US6399643 Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations formed therefrom
06/04/2002US6399637 Crystal modification of torasemide
06/04/2002US6399636 For therapy of asthma, chronic bronchitis, chronic obstructive pulmonary disease (copd), eosinophilic granuloma, psoriasis and septic shock, ulcerative colitis, crohn's disease, reperfusion injury of the myocardium and brain
06/04/2002US6399627 Anticoagulants; prothrominase, serine protease inhibitor; acrylamide derivatives
06/04/2002US6399626 Useful in inducing immunosuppression and in treatment of transplantation rejection, autoimmune diseases, solid tumors, fungal infections, vascular disease
06/04/2002US6399611 2-(4-ethoxycarbonylaminobenzyl)-6-(3,4 -dimethoxyphenyl)-2,3,4, 5-tetrahydropyridazin-3-one or alternately benzyl substituted compounds; phosphodiesterase iv and tumour necrosis factor inhibitors
06/04/2002US6399598 Diheterocyclic metalloprotease inhibitors
06/04/2002US6399573 Interleukin-1 receptor antagonist beta (IL-1rabeta)
06/04/2002US6399370 Compositions and methods for use of defensin
06/04/2002US6399104 Pharmaceutical compositions
06/04/2002US6399079 Spill resistant pharmaceutical compositions in semi-solid form
06/04/2002CA2331934A1 Protein and its encoding nucleotide sequences for diagnosis, prevention and treatment of lung injuries and disorders
06/04/2002CA2205198C Human neutrophil elastase inhibitors
05/2002
05/30/2002WO2002042437A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
05/30/2002WO2002042436A2 Isolated human phosphatase proteins, nucleic acid molecules encoding them, and uses thereof
05/30/2002WO2002042335A1 Polysaccharide compound having immune stimulating activity
05/30/2002WO2002042332A2 Truncated cd200
05/30/2002WO2002042326A1 A method of expression and agents identified thereby
05/30/2002WO2002042309A1 Indole derivatives and use thereof in medicines
05/30/2002WO2002042306A1 Benzimidazole derivatives, preparation and therapeutic use thereof
05/30/2002WO2002042303A2 Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents
05/30/2002WO2002042301A1 Novel pyridine-substituted pyrazolopyridine derivatives
05/30/2002WO2002042299A1 Novel lactame-substituted pyrazolopyridine derivatives
05/30/2002WO2002042298A1 Aminothiazoles and their use as adenosine receptor antagonists
05/30/2002WO2002042296A1 Farnesyl transferase inhibiting benzoheterocyclic derivatives
05/30/2002WO2002042292A2 Indol derivative and their use as inhibitors of p38 kinase
05/30/2002WO2002042280A2 Pyrimidine derivatives
05/30/2002WO2002042278A2 Imidazole and benzimidazole caspase inhibitors and uses thereof
05/30/2002WO2002042273A2 Acid derivatives useful as serine protease inhibitors
05/30/2002WO2002042272A2 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
05/30/2002WO2002042269A1 3-arylindole derivatives and their use as cb2 receptor agonists
05/30/2002WO2002041909A1 Method and preparations having effect against allergic symptoms
05/30/2002WO2002041896A2 Use of thienopyrimidines
05/30/2002WO2002041887A1 Dry syrup preparations
05/30/2002WO2002041885A2 Treatment of inflammation and associated complications using pseudohalides
05/30/2002WO2002041880A2 Use of pyrazolo[4,3-d]pyrimidines
05/30/2002WO2002041861A1 Rhinological agents
05/30/2002WO2002041837A2 Treatment of mucositis
05/30/2002WO2002022599A3 Chemokine receptor binding heterocyclic compounds
05/30/2002WO2002020736A9 Proteases
05/30/2002WO2001098270A3 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
05/30/2002WO2001092565A8 Diagnosis of diseases associated dna transcription by means of assessing the methylation status of genes associated with dna transcription
05/30/2002WO2001074780A8 Chemical complex comprising a pyridine carboxy derivative and an h2 histamine receptor antagonist
05/30/2002WO2001068888A3 Production of chimeric capsid vectors
05/30/2002WO2001066746A3 G-protein coupled receptor related polypeptides
05/30/2002WO2001042273A3 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
05/30/2002WO2000078952A8 Human rna metabolism proteins (rmep)
05/30/2002US20020065416 Anti-inflammatory agents
05/30/2002US20020065391 Compound for use in the treatment of arthritis, inflammatory bowel disease, nervous system and cardiovascular disorders, arteriosclerosis, restenoses, diabetes, grafted organ damage, asthma, allergies, tumor metastasis and malaria
05/30/2002US20020065326 Patient oxygenation using stabilized fluorocarbon emulsions
05/30/2002US20020065315 For therapy and prophylaxis of asthma, cystic fibrosis, chronic obstructive pulmonary disease and rhinorrhea, convulsions, vascular spasms, coronary artery spasms, renal disorders, polycystic kidney disease, bladder spasms, etc.